Spruce Biosciences Inc
NASDAQ:SPRB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spruce Biosciences Inc
NASDAQ:SPRB
|
US |
|
C
|
Cincinnati Financial Corp
XBER:CCJ
|
US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Ollie's Bargain Outlet Holdings Inc
NASDAQ:OLLI
|
US |
|
D
|
Dakota Gold Corp
AMEX:DC
|
US |
|
Fortinet Inc
NASDAQ:FTNT
|
US |
|
C
|
Conocophillips
BMV:COP
|
US |
|
China Minsheng Banking Corp Ltd
OTC:CGMBF
|
CN |
|
Star Diamond Corp
TSX:DIAM
|
CA |
|
F
|
Fortec Elektronik AG
XHAM:FEV
|
DE |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
|
Credito Emiliano SpA
MIL:CE
|
IT |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
G
|
General Mills Inc
DUS:GRM
|
US |
|
Voltas Ltd
NSE:VOLTAS
|
IN |
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
US |
Wall St Price Targets
SPRB Price Targets Summary
Spruce Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
SPRB is 190.332 USD with a low forecast of 141.4 USD and a high forecast of 297.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPRB's stock price target?
Price Target
190.332
USD
According to Wall Street analysts, the average 1-year price target for
SPRB is 190.332 USD with a low forecast of 141.4 USD and a high forecast of 297.15 USD.